Cold salt-water foot baths to prevent paclitaxel-related nerve damage
Official title: The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy
Run by Istanbul Topkapi University · NCT06964802 · Data updated 2026-11-12
This study tests whether taking cold salt-water or plain cold-water foot baths during paclitaxel chemotherapy can prevent or reduce chemotherapy-related peripheral nerve damage in women with breast cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Istanbul Topkapi University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul, Uskudar) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 1, 2025 |
| Study ends | July 1, 2026 |
| Registry record updated | April 16, 2026 |
| Trial ID | NCT06964802 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with breast cancer who speak Turkish, are scheduled to receive paclitaxel, and have no baseline chemotherapy-associated neuropathy or diabetes are the intended participants.
✕Probably not a fit
Patients with preexisting peripheral neuropathy, diabetes, foot wounds, peripheral vascular or central nervous system disease, or bone/soft-tissue metastases are unlikely to benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled trial that assigns Turkish-speaking women with breast cancer receiving paclitaxel to cold salt-water foot baths, unsalted cold-water foot baths, or standard care. Interventions are delivered during chemotherapy and participants are monitored over time using neuropathy screening tools such as the CIPNAT scale, monofilament testing, and vibration testing to track onset, severity, and functional impact. The primary aims are to reduce the incidence and severity of chemotherapy-induced peripheral neuropathy and its effects on daily activities. Key exclusion criteria include preexisting neuropathy, diabetes, foot ulcers, peripheral vascular or nervous system disease, and bone or soft tissue metastases.
Why it matters
Potential benefit: If successful, this low-cost, noninvasive approach could lower how often and how severely paclitaxel causes peripheral neuropathy and help patients keep better daily function.
How similar studies have gone: Related cryotherapy (frozen glove/boot) studies have shown some benefit in small trials, but the use of cold salt-water foot baths for CIPN prevention is relatively novel and not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 18 and over. * Conscious * Speaking and understanding Turkish * The diagnosis was breast cancer * Those who will receive paclitaxel chemotherapy * These are patients who answered 'no' to the 'A' section of the CIPNAT scale Exclusion Criteria: * Responding to the vibration test (if the practitioner does not feel the vibration when the patient says they feel the vibration, it means that neuropathy is present) * Feeling pressure in one or none of the three areas on the plantar surface of the foot according to the monofilament test * Previous chemotherapy-associated peripheral neuropathy * Diagnosed with diabetes * Open wounds or skin ulcers on the foot * With peripheral and central nervous system disease * Peripheral vascular disease, * Patients with bone or soft tissue metastases
Where it's running
-
Haydarpaşa Numune Training and Research Hospital
Istanbul, Uskudar, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Tuba Eryigit, PhD student
- Email: tubaeryigit@topkapi.edu.tr
- Phone: +905059683332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cryotherapy during weekly paclitaxel to reduce chemotherapy-induced numbness and tingling
This study tests whether applying cryotherapy to hands and feet during weekly paclitaxel helps prevent CIPN in women with breast cancer.
-
Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy
This study tests whether adding a structured exercise program to electroacupuncture helps cancer survivors with CIPN more than electroacupuncture alone.
-
Virtual exercise program to help with chemotherapy-induced nerve symptoms
This trial tests whether a remote, personalized exercise program (EX-CIPN) can reduce CIPN symptoms and related disability in cancer survivors who have persistent neuropathy after chemotherapy, compared with usual care.
-
Hyperbaric oxygen therapy for nab-paclitaxel-induced neuropathy in breast cancer
This study tests whether hyperbaric oxygen therapy can help relieve neuropathy from nab-paclitaxel in adult women with breast cancer who have finished chemotherapy.
-
Acupuncture and compression to prevent chemotherapy-induced nerve damage in breast cancer
This trial will test whether wearing compression garments and/or receiving acupuncture during taxane chemotherapy can prevent chemotherapy-induced peripheral neuropathy in adults with early-stage breast cancer.
-
PEA and Scutellaria combined with exercise for chemotherapy-related nerve pain
This trial will see if taking PEA and Scutellaria together with therapeutic exercise helps adults who have nerve pain after chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.